Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systems pharmacology, pharmacogenetics, and clinical trial design in network medicine
Authors
Keywords
-
Journal
Wiley Interdisciplinary Reviews-Systems Biology and Medicine
Volume 4, Issue 4, Pages 367-383
Publisher
Wiley
Online
2012-05-11
DOI
10.1002/wsbm.1173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Personalized Cardiovascular Medicine and Drug Development
- (2012) Joseph Loscalzo CIRCULATION
- The mystery of missing heritability: Genetic interactions create phantom heritability
- (2012) O. Zuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillation
- (2012) Jeanne Mendell et al. THROMBOSIS AND HAEMOSTASIS
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Regulatory Perspectives on Multiplicity in Adaptive Design Clinical Trials throughout a Drug Development Program
- (2011) Sue-Jane Wang et al. Journal of Biopharmaceutical Statistics
- Systematic exploration of synergistic drug pairs
- (2011) M. Cokol et al. Molecular Systems Biology
- Translational research: 4 ways to fix the clinical trial
- (2011) Heidi Ledford NATURE
- The Risks and Benefits of Indacaterol — The FDA's Review
- (2011) Badrul A. Chowdhury et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Benefits, challenges and obstacles of adaptive clinical trial designs
- (2011) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- How a new stratified adaptive phase II design could improve targeting population
- (2011) Caroline Tournoux-Facon et al. STATISTICS IN MEDICINE
- Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication
- (2011) Roger J Lewis et al. Trials
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) Study
- (2010) Tmirah Haselkorn et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) S. P. Ivy et al. CLINICAL CANCER RESEARCH
- Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials
- (2010) Sue-Jane Wang et al. Clinical Trials
- Adaptive design clinical trials: Methodology, challenges and prospect
- (2010) Rajiv Mahajan et al. INDIAN JOURNAL OF PHARMACOLOGY
- Review of Draft FDA Adaptive Design Guidance
- (2010) Thomas Cook et al. Journal of Biopharmaceutical Statistics
- Quantitative clinical pharmacology is transforming drug regulation
- (2010) Carl C. Peck JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Network medicine: a network-based approach to human disease
- (2010) Albert-László Barabási et al. NATURE REVIEWS GENETICS
- Integrating indacaterol dose selection in a clinical study in COPD using an adaptive seamless design
- (2010) Peter J. Barnes et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Adaptive increase in sample size when interim results are promising: A practical guide with examples
- (2010) Cyrus R. Mehta et al. STATISTICS IN MEDICINE
- The Prevalence of Nonadherence in Difficult Asthma
- (2009) Jacqueline Gamble et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Optimizing Trial Design
- (2009) Cyrus Mehta et al. CIRCULATION
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetic Mapping of Pharmacogenetic Regulatory Variation
- (2009) Benjamin Raby CURRENT PHARMACEUTICAL DESIGN
- Spending on new drug development
- (2009) Christopher Paul Adams et al. HEALTH ECONOMICS
- The future of drug development: advancing clinical trial design
- (2009) John Orloff et al. NATURE REVIEWS DRUG DISCOVERY
- Adaptive designs for confirmatory clinical trials
- (2009) Frank Bretz et al. STATISTICS IN MEDICINE
- The Discovery of Statins
- (2008) Thomas P. Stossel CELL
- Mathematical Modeling of Corticosteroid Pharmacogenomics in Rat Muscle following Acute and Chronic Methylprednisolone Dosing
- (2008) Zhenling Yao et al. MOLECULAR PHARMACEUTICS
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- Molecular basis for statin-induced muscle toxicity: implications and possibilities
- (2008) Catherine Buettner et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now